CASM CAS Medical Systems

CASMED to Present at the 11th Annual LD Micro Main Event Conference on December 5

CASMED to Present at the 11th Annual LD Micro Main Event Conference on December 5

BRANFORD, Conn., Nov. 28, 2018 (GLOBE NEWSWIRE) -- CAS Medical Systems, Inc. (NASDAQ: CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, announces that Thomas M. Patton, President and Chief Executive Officer, will present at the 11th Annual LD Micro Main Event Conference on Wednesday, December 5, 2018, at 11:00 a.m. Pacific time (2:00 p.m. Eastern time). The conference is being held at the Luxe Sunset Boulevard Hotel in Los Angeles.

Management will be available for one-on-one meetings with the investment community on Wednesday, December 5. Please contact LD Micro at if you would like to arrange a meeting.

Interested parties can access the audio webcast with slide presentation at . An archived presentation will be available for 90 days.

About CASMED® – Monitoring What's Vital

CASMED’s vision is:  “That no patient is harmed by undetected tissue hypoxia.”  Our FORE-SIGHT® Cerebral Oximeters provide a highly accurate, non-invasive measurement of tissue oxygenation in the brain.  Direct monitoring of tissue oxygenation can provide clinicians with a superior and powerful tool to alert them to otherwise unrecognized and dangerous hypoxia, or low levels of oxygen, in the brain and other tissue, thereby empowering them to improve patient care.  For further information regarding CASMED, visit the Company's website at .

Company Contact

CAS Medical Systems, Inc.

Jeffery A. Baird

Chief Financial Officer

(203) 315-6303





Investors

LHA Investor Relations

Bruce Voss / Jody Cain

(310) 691-7100



@LHA_IR_PR

EN
28/11/2018

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on CAS Medical Systems

 PRESS RELEASE

CASMED Reports Preliminary Net Sales for the 2018 Fourth Quarter and F...

CASMED Reports Preliminary Net Sales for the 2018 Fourth Quarter and Full Year Record Q4 FORE-SIGHT® cerebral oximetry sales drive 18% full-year FORE-SIGHT sales growth Introduces 2019 FORE-SIGHT sales guidance BRANFORD, Conn., Jan. 03, 2019 (GLOBE NEWSWIRE) -- CAS Medical Systems, Inc. (NASDAQ: CASM) (CASMED), a leader in non-invasive cerebral oximetry patient monitoring, reports preliminary unaudited topline results for the three and 12 months ended December 31, 2018. The Company expects net sales from continuing operations for the fourth quarter of 2018 to be approximately $5.8 mill...

 PRESS RELEASE

CASMED to Present at the 11th Annual LD Micro Main Event Conference on...

CASMED to Present at the 11th Annual LD Micro Main Event Conference on December 5 BRANFORD, Conn., Nov. 28, 2018 (GLOBE NEWSWIRE) -- CAS Medical Systems, Inc. (NASDAQ: CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, announces that Thomas M. Patton, President and Chief Executive Officer, will present at the 11th Annual LD Micro Main Event Conference on Wednesday, December 5, 2018, at 11:00 a.m. Pacific time (2:00 p.m. Eastern time). The conference is being held at the Luxe Sunset Boulevard Hotel in Los Angeles. Management will be available for one-on-one m...

 PRESS RELEASE

CASMED Reports Third-Quarter 2018 Financial Results

CASMED Reports Third-Quarter 2018 Financial Results FORE-SIGHT® sales increase 20%; sensor sales up 22% on 20% growth in the U.S.; operating loss narrows by 25% Conference Call Begins at 10:00 a.m. Eastern Time Today BRANFORD, Conn., Oct. 31, 2018 (GLOBE NEWSWIRE) -- CAS Medical Systems, Inc. (NASDAQ: CASM) (“CASMED” or the “Company”), a leader in medical products for non-invasive patient monitoring of tissue oxygenation, today reported financial results for the three and nine months ended September 30, 2018. Net sales from continuing operations for the third quarter of 2018 were $5.4 ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch